The Independent Payment Advisory Board will not impose cuts in U.S. government payments to drugmakers in 2015 due to the slow growth of Medicare spending, according to a memo from the actuary for CMS. "Since the Affordable Care Act was enacted, growth in Medicare per capita spending has slowed significantly, putting Medicare on a more sustainable path to keep its commitment to seniors and persons with disabilities today and well into the future," CMS spokesman Brian Cook said in e-mail.

Full Story:

Related Summaries